Hansa Biopharma AB (publ) (STO:HNSA)
33.40
+0.18 (0.54%)
At close: Dec 5, 2025
Hansa Biopharma AB Employees
Hansa Biopharma AB had 135 employees as of December 31, 2024. The number of employees decreased by 33 or -19.64% compared to the previous year.
Employees
135
Change (1Y)
-33
Growth (1Y)
-19.64%
Revenue / Employee
1.34M SEK
Profits / Employee
-4.82M SEK
Market Cap
3.40B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Swedish Orphan Biovitrum AB | 1,806 |
| Getinge AB | 11,791 |
| Sectra AB | 1,296 |
| Camurus AB | 256 |
| Medicover AB | 47,256 |
| Asker Healthcare Group AB | 4,030 |
| BioArctic AB | 107 |
| AddLife AB | 2,181 |
Hansa Biopharma AB News
- 23 days ago - Hansa Biopharma AB (publ) (HNSBF) Discusses Phase III Trial Data and Developments in IgG-Cleaving Platform for Kidney Transplantation and Autoimmune Diseases Transcript - Seeking Alpha
- 23 days ago - Hansa Biopharma AB (publ) (HNSBF) Discusses Phase III Trial Data and Developments in IgG-Cleaving Platform for Kidney Transplantation and Autoimmune Diseases - Slideshow - Seeking Alpha
- 5 weeks ago - Hansa Biopharma AB (publ) 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 5 weeks ago - Hansa Biopharma AB (publ) (HNSBF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Hansa Biopharma AB (HNSBF) Q3 2025 Earnings Call Highlights: Strategic Advances Amidst Revenue ... - GuruFocus
- 5 weeks ago - Q3 2025 Hansa Biopharma AB Earnings Call Transcript - GuruFocus
- 5 weeks ago - Hansa Biopharma Reports Third Quarter and Interim Year to Date 2025 Financial Results - PRNewsWire
- 5 weeks ago - Hansa hosts call with distinguished transplant surgeons: Insights on clinical practice and imlifidase Phase 3 Results - PRNewsWire